In a patient presenting with chest pain who has an implanted pacemaker, should the pacemaker be interrogated promptly?

Should a Pacemaker Be Interrogated in a Patient Presenting with Chest Pain?

Yes, pacemaker interrogation should be performed in patients with chest pain, as it can provide critical diagnostic information about device function, arrhythmias, and potential complications that may be causing or contributing to symptoms.

Clinical Rationale

When a patient with an implanted pacemaker presents with chest pain, device interrogation serves multiple essential diagnostic purposes:

Primary Diagnostic Value

Device interrogation can identify:

• Pacemaker malfunction including failure to capture or sense appropriately, which may result from lead fractures, loose set screws, cardiac perforation, or lead dislodgement 1
• Stored arrhythmia data that may reveal paroxysmal atrial or ventricular arrhythmias responsible for symptoms 2, 3
• Pacemaker-mediated tachycardia where the device tracks atrial tachycardias, causing symptoms 2
• Lead complications including perforation, which can present with atypical symptoms including chest or abdominal pain 4

Timing Considerations

The diagnostic yield varies significantly based on timing:

Early post-implantation (first weeks to months):

• Higher risk period for acute complications including lead dislodgement (1-2% for pacemakers, up to 5.7% for cardiac resynchronization devices) 1
• Lead perforation may occur acutely, subacutely, or as delayed complication 4
• Device interrogation is particularly valuable in this timeframe 3

Late post-implantation:

• Lower but still present risk of device-related issues
• Interrogation may reveal battery depletion, lead integrity problems, or programming issues 5

Practical Implementation

When to Interrogate

Interrogation should be performed when:

• Any patient with a pacemaker presents with chest pain, especially if:
  • Recent device implantation (within months)
  • Concerning physical exam findings
  • Abnormal telemetry or ECG findings
  • Symptoms suggesting arrhythmia (palpitations, syncope, presyncope)

Who Should Perform Interrogation

The 2011 ASA Practice Advisory recommends consultation with a cardiologist or pacemaker-ICD service for device interrogation 6. However, research demonstrates that emergency department personnel can safely and quickly interrogate devices (taking <10 minutes in 89% of cases), with ED physicians reporting the data assisted patient care in 60% of cases 7.

What to Assess During Interrogation

Key parameters to evaluate:

• Battery status and device function
• Pacing and sensing thresholds
• Lead impedance and integrity
• Stored arrhythmia episodes and mode-switching events
• Evidence of inappropriate sensing or pacing
• Capture verification (whether pacing produces mechanical systole) 6

Important Caveats

Diagnostic Yield Limitations

While interrogation is recommended, the actual diagnostic yield for syncope evaluation is relatively low (4-5% in one study) when there are no concerning physical exam, telemetry, or ECG findings 3. However, when positive, the findings can be critical and alter management.

Integration with Standard Workup

Pacemaker interrogation should complement, not replace, standard chest pain evaluation:

• ECG should still be obtained within 10 minutes 8
• Cardiac troponins should be measured as soon as possible 8
• History remains the most important diagnostic tool (36% diagnostic yield) 3

Common Pitfalls to Avoid

1. Don't assume chest pain is unrelated to the device - Lead perforation can present with atypical pain patterns, including abdominal pain 4
2. Don't delay interrogation waiting for manufacturer representatives - ED personnel can safely perform this with appropriate training 7
3. Don't skip interrogation in pacemaker-dependent patients - These patients are at highest risk if device malfunction occurs 6

Clinical Algorithm

For patients with pacemakers presenting with chest pain:

1. Immediate assessment (within 10 minutes):

   • Obtain 12-lead ECG
   • Assess hemodynamic stability
   • Place on continuous cardiac monitoring

2. Determine urgency of interrogation:

   • Urgent (immediate): Hemodynamic instability, concerning ECG/telemetry findings, recent implantation (<6 months), pacemaker-dependent patient
   • Prompt (within hours): Stable patient with chest pain and pacemaker

3. Perform interrogation:

   • Contact device clinic/cardiologist OR
   • Use ED-based interrogation if personnel trained and equipment available

4. Concurrent standard chest pain workup:

   • Serial troponins
   • Risk stratification for ACS
   • Consider other causes (PE, aortic dissection, etc.)

The key principle: Device interrogation provides unique diagnostic information not available through standard testing and should be incorporated into the comprehensive evaluation of chest pain in pacemaker patients, particularly when symptoms are unexplained or device-related complications are suspected.